News
China has leaped from fast follower to global pioneer in drug discovery and development. We believe that Chinese companies ...
A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more ...
A new report from Pitchbook suggests we’re in for a period of more sustainable investing, with VC firms continuing to create ...
Brooklyn's business park in Sunset Park, Industry City, continues to see tenant demand. Biotech firms Cresilon and Rumi ...
Regencell's stock soared 17,000% fueled by speculation, despite no revenue or clinical progress. Read why I think the RGC ...
French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for up to $9.5 billion, sending shares of ...
Story May 12 - NGM Bio: The biotech is shedding around 75% of staff, pausing development of a phase 2 liver disease asset and halting further investment in discovery and preclinical work.
Father’s Day is June 15. Cope’s bespoke Calico Wallpaper’s newest line, Overture, gives the illusion of drapery, and was made with British lighting designer Lee Broom. Cope has two children.
Fierce Biotech Fundraising Tracker '25: Allay accesses $57M series D; SpyGlass secures $75M series D
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...
Alongside the flood of investment into biotechs working on potential COVID-19-related products, all types of biotech financing became easier to access, providing a major boost to companies looking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results